Amerisource Recalls Paroxetine Tablets Due to Foreign Object Presence
Amerisource Health Services is recalling specific lots of Paroxetine tablets because they contain foreign tablets or capsules.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (foreign objects in medication) where injury has not yet been reported, fitting the 'High' severity criteria.
Plain-English summary
Amerisource Health Services is recalling 74 cartons of Paroxetine Tablets, USP, 30mg. The product is distributed by American Health Packaging in Columbus, Ohio, and is identified by NDC 68084-046-01 and Lot 172291.
The recall was initiated due to the presence of foreign tablets or capsules in the product. The affected units were distributed nationwide in the USA.
Consumers and healthcare providers should check their inventory for the specific lot number and NDC listed above. If the product is found, it should be removed from use and returned to the distributor or manufacturer for further instructions.
The recalled product
- Product
- PAROXETINE (PAROXETINE)
- Brand
- PAROXETINE
- Manufacturer
- Amerisource Health Services
- Category
- Drug — Prescription Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 172291
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · PAROXETINE
- ModerateParoxetine Tablets Recalled Due to Manufacturing Specification Failure
FDA (Drugs) · 2023-12-06
- ModerateParoxetine 20 mg Tablets Recalled for Out-of-Specification Impurity
FDA (Drugs) · 2023-12-06
- HighParoxetine Hydrochloride Tablets Recalled for Out-of-Specification Impurity
FDA (Drugs) · 2023-12-06
- HighParoxetine Tablets Recalled Due to Out-of-Specification Impurity Levels
FDA (Drugs) · 2023-12-06
- HighParoxetine Hydrochloride 30 mg Tablets Recalled for Impurity Specification Failure
FDA (Drugs) · 2023-12-06
Same manufacturer · Amerisource Health Services
See all →- LowAmerisource Recalls Enalapril Maleate Tablets Due to Stability Failures
FDA (Drugs) · 2017-11-22
- ModerateAmerisource Recalls Glipizide Extended-Release Tablets Due to Dissolution Failure
FDA (Drugs) · 2017-03-22
- ModerateCyclosporine Capsules Recalled for Impurity Specification Failures
FDA (Drugs) · 2017-03-08
- ModerateAHP Nifedipine Capsules Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2016-11-30
- ModerateAmerisource Recalls Bupropion Hydrochloride Extended-Release Tablets for Dissolution Failure
FDA (Drugs) · 2016-11-23
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02